# The Effective and Safety of Thalidomide in NTDT

> **NCT02995707** · PHASE2 · UNKNOWN · sponsor: **Xiao-Lin Yin** · enrollment: 30 (estimated)

## Conditions studied

- Thalassemia

## Interventions

- **DRUG:** Thalidomide

## Key facts

- **NCT ID:** NCT02995707
- **Lead sponsor:** Xiao-Lin Yin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2017-12
- **Final completion:** 2018-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02995707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02995707, "The Effective and Safety of Thalidomide in NTDT". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02995707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*